Natick, United States
SBH Sciences is a preclinical Contract Research Organization (CRO) focused on anti-cancer and anti-inflammation drug development, serving the Greater Boston area for 27 years. It has garnered recognition for product quality, service excellence, and timely delivery, collaborating with over 300 biotechnology and diagnostic companies.
The company offers a diverse range of products and services, including incubator-model support for early-stage biotechnology companies, as well as cell-based discovery, cytokines and enzyme production, and immunological and analytical services. With the most comprehensive collection of 330 cytokine bioassays in the US, SBH Sciences is actively involved in cytotoxicity testing, biomarker measurement, functional activity testing, in-vivo modeling, diagnostics, and kinase screening services. Notably, they possess over 370 human cancer cell lines for in-vitro oncology lead drug screening. Additionally, the company provides 11 biomarkers platforms, encompassing fully automatic ELISA workstation, Luminex, Automatic Western Blot (PeggySue, WES, and Jess), ELLA, MSD, HTRF, Alpha-Lisa, FACS, Iso-Light, HPLC, and qRT-PCR.
Established in 1997, SBH Sciences operates within the Biotechnology industry, and has its headquarters in the United States.
For further information about the company's products and services, visit SBH Sciences Website.
Ichor Life Sciences, Inc.
